Phase 4 Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman who has gone through menopause and has been diagnosed with osteoporosis (thinning of the bones)
- You have been taking a medication called denosumab for at least 2 years, and your doctor has decided it is time to stop it because your treatment has gone well (no new broken bones, no new risk factors, and your bone density has not dropped significantly)
- Before you started denosumab, you either had a serious fracture (broken bone) or your bone density scan showed significantly low bone density in your spine or hip
Who may not be able to join:
- You were taking denosumab for a bone condition other than menopause-related osteoporosis
- You have an endocrine (hormonal) disease that is not well controlled, or you have liver failure
- You have taken certain medications that affect bone health in the past year, including bisphosphonates, teriparatide, romosozumab, certain hormone-related drugs, or steroid tablets at higher doses (confirm with trial site)
- You have kidney disease that is moderately severe or worse, or you have previously had a bad reaction to a medication called zoledronic acid
- You are not able to give your own consent to take part, or you are unable to complete study forms, or you are under legal protection (confirm with trial site)
- You are unlikely to follow the study plan reliably, or you have issues with alcohol or drug dependency
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 05 61 77 73 75
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maintain lumbar bone mineral density (BMD) after 1 year of ZOL
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.